OSLO (Reuters) – Norway will not resume the use of COVID-19 vaccines made by AstraZeneca, while a decision on whether to start using inoculations made by Johnson & Johnson’s remains on hold, Prime Minister Erna Solberg said on Wednesday.
A government-appointed commission had recommended that both vaccines should be excluded from Norway’s vaccination programme due to a risk of rare but harmful side-effects.
(Reporting by Terje Solsvik, editing by Nerijus Adomaitis)
